Veradermics (MANE) Enterprise Value (2024 - 2026)

Veradermics (MANE) has 3 years of Enterprise Value data on file, last reported at -$390.8 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value changed N/A year-over-year to -$390.8 million; the trailing twelve-month figure through Mar 2026 stood at -$390.8 million (changed N/A YoY), and the FY2025 full-year result was -$141.9 million, down 167.24% from the prior year.
• Enterprise Value for Q1 2026 stood at -$390.8 million, down from -$141.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$53.1 million in Q4 2024 and bottomed at -$390.8 million in Q1 2026.
• The 3-year median for Enterprise Value is -$141.9 million (2025), against an average of -$195.2 million.
• Peak annual rise in Enterprise Value reached 167.24% in 2025, while the deepest fall reached 167.24% in 2025.
• A 3-year view of Enterprise Value shows it stood at -$53.1 million in 2024, then slumped by 167.24% to -$141.9 million in 2025, then sank by 175.48% to -$390.8 million in 2026.
• The last three Enterprise Value figures came in at -$390.8 million (Q1 2026), -$141.9 million (Q4 2025), and -$53.1 million (Q4 2024), per Business Quant data.

Peer Comparison